SUMMARY: HGPS is a rare syndrome of segmental premature aging. Our goal was to expand the scope of structural bone and soft-tissue craniofacial abnormalities in HGPS through CT or MR imaging. Using The Progeria Research Foundation Medical and Research Database, 98 imaging studies on 25 patients, birth to 14.1 years of age, were comprehensively reviewed. Eight newly identified abnormalities involving the calvaria, skull base, and soft tissues of the face and orbits were present with prevalences between 43% and 100%. These included J-shaped sellas, a mottled appearance and increased vascular markings of the calvaria, abnormally configured mandibular condyles, hypoplastic articular eminences, small zygomatic arches, prominent parotid glands, and optic nerve kinking. This expanded craniofacial characterization helps link disease features and improves our ability to evaluate how underlying genetic and cellular abnormalities culminate in a disease phenotype. Children with HGPS typically appear healthy at birth and within the first year of life develop severe failure to thrive with sclerodermatous skin changes. 8,9 Classic craniofacial features develop with age and underlying disease culminates in death from myocardial infarction or stroke at an average age of 13 years. 8,10 Close examination of common and disparate findings in HGPS and aging may inform both fields of study. Clinical features that resemble premature aging include alopecia, joint contractures, progressive mandibular resorption, low bone density, lipoatrophy with limb wasting, and global atherosclerosis. 8,11 Age-related conditions such as Alzheimer disease, dementia, osteoarthritis, and cancer are absent. Cognitive function and motor development are normal. In addition, there is growth failure, skeletal dysplasia, and lack of pubertal development.
ABBREVIATIONS
12Prior reports of craniofacial features are based on plain film findings and autopsy results. 10,13,14 In this study of a large cohort of patients with HGPS, we reviewed CT, MR imaging, and radiographs to quantify previously noted and new craniofacial imaging features to expand our understanding of the natural history of the disease.
Materials and Methods
Patients and DataPatients were identified from The Progeria Research Foundation Medical and Research Database (Brown University Center for Gerontology and Healthcare Research, Providence, Rhode Island). Eligible individuals had a genetic and/or clinical diagnosis of HGPS and at least 1 MR or CT of the head or neck available for review. The diagnosis of HGPS was genetically determined by either the classic exon 11 (c. 1824 CϾT) or a nonclassic progerin-producing LMNA mutation within exon 11 or the exon/intron border, plus the typical clinical phenotype.
15Data abstraction included indications for neuroimaging studies, OFC, and medications. Height-age was determined by using the CDC and WHO child growth standards for boys and girls. 16,17 Abstracted OFC measurements from patient charts were expressed as percentiles by height-age.
Neuroimaging Stu...